SCHEMBL31511192

SCHEMBL31511192

CC(C)(C)OC(=O)N1CCCCC1C(=O)ON1C(=O)c2ccccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.48
▸ UCHL1 P09936 4/20 0.47
▸ KLK7 P49862 1/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ LMNA P02545 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ FKBP1A P62942 3/20 0.43
▸ HSD11B1 P28845 1/20 0.43
▸ HSD17B10 Q99714 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23975515 1.00 EPHX2 (0.48) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL28459867 0.97 EPHX2 (0.51) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL30537463 0.97 EPHX2 (0.51) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL31510905 0.97 EPHX2 (0.51) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL22715472 0.92 EPHX2 (0.43) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL23975412 0.87 UCHL1 (0.44) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL23975520 0.83 EPHX2 (0.44) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL30954452 0.83 UCHL1 (0.39) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL21848418 0.82 KLK7 (0.39) EPHX2UCHL1KLK7NPC1MEN1
SCHEMBL10347006 0.82 HSD17B10 (0.46) EPHX2UCHL1KLK7NPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-09-04 — — US disclosed
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-04-17 — — US disclosed
WO-2025074249-A1 NITROGEN-LINKED BENZISOXAZOLE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER PFIZER INC. (US) 2025-04-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 EPHX2 3646/4885UCHL1 2401/4885KLK7 3363/4885
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 EPHX2 3626/4885UCHL1 2452/4885KLK7 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback